Value, Access & Regulatory Evidence Workshop

Acknowledging the different perspectives and finding the pragmatic way forward

Back to Agenda

Session 7: Joint Clinical Assessment (REA) Workshop

Session Chair(s)

Claudine Sapède, PharmD

Director, Global HTA Policy

NOVARTIS INTERNATIONAL, Switzerland

This session will provide the opportunity for the audience to actively participate through small group discussions and share experience on a selection of themes related to JCA. Panellists from session 6 will join to facilitate support the group. • Uptake of REA Reports • Interface between JCA and National HTA Agencies Assessments • Methodological Quality Standards and Implications for Evidence Generation Development • Industry Preparedness for JCA Dossier Submission